Akido is a pioneering AI-native healthcare company dedicated to dismantling barriers in the medical field. By integrating advanced technology like their proprietary ScopeAI clinical platform with a robust nationwide medical network, Akido addresses critical physician shortages while scaling risk-bearing care models to improve patient outcomes.
With $60 million in Series B funding, Akido is rapidly expanding its footprint across the United States, operating in 26 specialties. Their culture thrives on innovation, social impact, and a shared passion for transforming the future of healthcare delivery for everyone.